The media will almost never report on an OTC stock because they know that by doing so they will be supplying the credibility and potentially causing an OTC stock to explode higher. Business outlets like CNBC or the other big name business media companies are going to be especially aware of the impact they can have on an OTC stock.

The media does not want to be the first entity to provide an OTC company crediblity. We need something else to make the first move on Leronlimab and the media will follow.